Basic Sciences

July 19, 2018

Fueling the MATE transporter

Vanderbilt researchers used spectroscopy to understand how a drug transporter pumps drugs out of cells, findings that are important for developing novel anti-cancer and anti-bacterial drugs that can overcome drug resistance.

By Sanjay Mishra
June 29, 2018

Scavengers “protect” HDL

Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease.

By Bill Snyder
June 21, 2018

Roden’s circulatory diseases research honored

Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.

By Bill Snyder
June 21, 2018

Roden’s circulatory diseases research honored

Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.

By Bill Snyder
June 11, 2018

Confronting TB resistance

Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.

By Niyati Vachharajani
June 8, 2018

$8.1 million grant funds new center to research highly aggressive form of lung cancer

A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.

By Bill Snyder
June 7, 2018

Enzyme protects against obesity-related heart disease

Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.
By Sanjay Mishra
May 24, 2018

Seven interdisciplinary programs land TIPs awards for 2018

Vanderbilt University’s transformational Trans-Institutional Programs initiative heads into a fourth year with grants awarded to seven interdisciplinary projects that involve more than 60 faculty members.
By VUMC News and Communications
May 18, 2018

Shaping reward circuits

Using techniques to control and monitor the activities of individual neurons, Vanderbilt investigators are probing the brain’s reward circuitry.
By Leigh MacMillan
May 1, 2018

Looking beyond the ‘magic bullet’ approach to drug discovery

Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.
By VUMC News and Communications
April 23, 2018

Toxin floats on lipid rafts

The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells.
By Leigh MacMillan
April 19, 2018

How the skin protects

Treatments for common skin conditions such as atopic dermatitis may be improved by understanding the enzymes responsible for forming the skin’s water-tight barrier.
By Sanjay Mishra
April 11, 2018

“Idling” cancer cells may return

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.
By Bill Snyder
1 … 10 11 12 13 14 … 17